Current research focuses on mitochondrial DNA mutations, the regulation of hypoxia-inducible factor (HIF-1α), and alterations in key enzymes such as hexokinase-II (HK-II), and their effects on tumor cells’ response to chemotherapy. The gene discussed is HIF1A; the disease is neoplasm.